Western blot confirmed that MXD1 expression was significantly downregulated in glioma cells transfected with tRF-22 mimic and upregulated in those transfected with tRF-22 inhibitor (Fig. 4I). The gene discussed is MXD1; the disease is central nervous system cancer.